Global Myopia & Presbyopia Treatment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• Advancements in Laser Technology: There have been notable advancements in laser technologies used in refractive surgeries such as LASIK and SMILE. These technologies continue to improve precision, safety, and outcomes for patients undergoing corrective procedures for myopia and presbyopia.
• Emergence of Extended Depth of Focus (EDOF) Lenses: EDOF lenses have gained attention as an alternative to traditional multifocal lenses for presbyopia. These lenses provide a continuous range of vision from near to intermediate distances, reducing dependence on reading glasses and improving overall visual quality.

This report offers a comprehensive exploration of the Global Myopia & Presbyopia Treatment Market through detailed segmentation and thorough analysis. It meticulously examines various segments within the market, including corrective treatments such as prescription lenses (single vision, bifocal, trifocal, and others), contact lenses, surgical interventions, and pharmacological approaches.

Each segment is scrutinized using a robust analytical framework that includes both historic and forecasted revenue analyses. Historical data provides a foundation for understanding market trends over time, while forecasted data offers insights into future market potential. These analyses are supported by a wealth of relevant data points meticulously gathered and interpreted.

Insights derived from data trends and patterns play a pivotal role in the report, enriching the analysis with actionable intelligence. These insights highlight key growth drivers, challenges, opportunities, and emerging trends within each segment. For instance, technological advancements in laser surgery techniques or the emergence of extended depth of focus (EDOF) lenses for presbyopia are thoroughly analyzed to assess their impact on market dynamics.

Furthermore, the report addresses regional variations in market behavior, regulatory influences, and economic factors shaping the adoption of myopia and presbyopia treatments worldwide. This holistic approach ensures that stakeholders, including investors, healthcare providers, and policymakers, gain a nuanced understanding of market dynamics and make informed decisions.

Global Myopia & Presbyopia Treatment Segment Analysis

In this report, the Global Myopia & Presbyopia Treatment Market has been segmented by Myopia Treatment Type, Presbyopia Treatment Type and Geography.

Global Myopia & Presbyopia Treatment Market, Segmentation by Myopia Treatment Type

The Global Myopia & Presbyopia Treatment Market has been segmented by Myopia Treatment Type into Corrective(Prescription Lenses(Single, Bifocal, Trifocal and Others) and Contact Lenses), Surgical and Drugs.

Reading Glasses: These are fundamental lenses designed to enhance near vision for tasks like reading or using a computer. They provide a simple and effective solution for individuals experiencing difficulty with close-up activities due to presbyopia.

Bifocals and Trifocals: These lenses feature distinct segments that correct vision at multiple distances. Bifocals have two segments (near and distance vision), while trifocals add an intermediate segment. They allow wearers to transition seamlessly between near, intermediate, and distance vision without needing multiple pairs of glasses.

Progressive Multifocals and Office Progressives: These advanced lenses offer a gradual change in prescription strength from the top to the bottom of the lens. Progressive multifocals provide a smooth transition between near, intermediate, and distance vision, catering to various daily activities. Office progressives are optimized for intermediate and near vision, ideal for office work or tasks requiring clear vision at arm's length.

Bifocal and Multifocal Contact Lenses: Similar to their spectacle counterparts, these contacts correct both near and distance vision. They offer an alternative to glasses, providing natural-looking vision correction and flexibility for active lifestyles.

Monovision and Modified Monovision: These techniques involve fitting one eye with a lens for near vision and the other for distance vision. Alternatively, modified monovision balances near and distance correction in both eyes. These approaches can reduce the need for reading glasses, offering freedom from traditional corrective eyewear.

Global Myopia & Presbyopia Treatment Market, Segmentation by Presbyopia Treatment Type

The global myopia and presbyopia treatment market is divided into several segments based on presbyopia treatment type, offering diverse solutions tailored to varying patient needs. Prescription lenses are a key category within this market, providing traditional yet effective remedies for presbyopia. Options include reading glasses, bifocals, trifocals, progressive multifocals, and office progressives. These solutions cater to individuals seeking clear vision at specific distances or a seamless transition between multiple focal lengths, making them a popular choice for presbyopia management. Their widespread accessibility and affordability have contributed to their sustained demand across different age groups.

Contact lenses represent another significant segment in presbyopia treatment, offering a more discreet and convenient alternative to glasses. Subcategories include bifocal, multifocal, monovision, and modified monovision lenses, each designed to correct vision for patients requiring clarity at near, intermediate, and far distances. The customization and advanced designs of these lenses have enhanced their appeal among active individuals and those seeking comfort and style without compromising visual acuity.

Intraocular lenses and refractive surgery complete the spectrum of presbyopia treatments, addressing more permanent or surgical solutions. Intraocular lenses are typically implanted during procedures like cataract surgery, providing patients with a long-lasting resolution for presbyopia. Refractive surgeries, including LASIK and other advanced techniques, reshape the cornea to improve focusing ability, offering a corrective option for patients who prefer a non-lens-based approach. These advanced treatments cater to individuals seeking greater convenience and are often favored by those with progressive presbyopia or coexisting refractive errors.

Global Myopia & Presbyopia Treatment Market, Segmentation by Geography

In this report, the Global Myopia & Presbyopia Treatment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Myopia & Presbyopia Treatment Market Share (%), by Geographical Region, 2024

North America traditionally holds a significant portion of the market share due to advanced healthcare facilities, higher awareness, and early adoption of technological innovations in vision correction. Europe follows closely, driven by a similarly developed healthcare system and increasing prevalence of refractive errors among the population.

Asia-Pacific exhibits rapid growth in market share, attributed to the large population base, rising disposable incomes, and increasing urbanization leading to higher incidence of myopia and presbyopia. Countries like China and India contribute substantially to this growth, supported by healthcare reforms and improving access to treatment options.

Latin America and Middle East & Africa regions show moderate market shares, influenced by improving healthcare infrastructure and rising healthcare expenditure. These regions are also seeing a gradual increase in awareness and accessibility to advanced vision correction treatments.

This report provides an in depth analysis of various factors that impact the dynamics of Global Myopia & Presbyopia Treatment Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers:

• Technological advancements in eyewear
• Increasing prevalence worldwide
• Growing elderly population
• Rising awareness campaigns

• Innovation in surgical techniques - Innovation in surgical techniques represents a pivotal driver in the global myopia and presbyopia treatment market. Traditional surgical approaches like LASIK (Laser-Assisted In Situ Keratomileusis) have evolved significantly, with advancements focusing on enhancing precision, safety, and outcomes for patients.

  Recent innovations include the introduction of femtosecond laser technology, which allows for more precise corneal flap creation during LASIK procedures. This reduces the risk of complications and enhances post-operative visual outcomes. Additionally, developments in intraocular lenses (IOLs) have expanded treatment options for presbyopia, offering multifocal and accommodating lenses that mimic the natural focusing ability of the eye.

  Moreover, minimally invasive surgical techniques such as small incision lenticule extraction (SMILE) have gained popularity. SMILE offers advantages over traditional LASIK by preserving corneal biomechanical stability and reducing dry eye symptoms post-surgery. These advancements not only improve patient comfort but also widen the demographic of candidates eligible for refractive surgery.

  Furthermore, ongoing research in regenerative medicine holds promise for future surgical innovations. Techniques such as corneal collagen cross-linking (CXL) aim to stabilize the cornea in patients with progressive myopia, potentially preventing the need for more invasive procedures later in life.

Restraints:

• Affordability concerns persist
• Limited access in rural areas
• Regulatory challenges globally
• Safety concerns in surgeries

• Economic downturn effects - Economic downturn effects pose significant restraints on the global myopia and presbyopia treatment market. During periods of economic instability, consumer spending on elective healthcare services, including refractive surgery and advanced vision correction treatments, often declines. This reduced spending can be attributed to individuals prioritizing essential expenses over discretionary healthcare expenditures.

  Moreover, economic downturns impact healthcare budgets and reimbursement policies, potentially limiting access to subsidized treatments and surgical procedures for myopia and presbyopia. Healthcare providers may face financial pressures, leading to cost-cutting measures that affect service quality and availability.

  Furthermore, fluctuations in currency exchange rates and inflation rates can increase the overall cost of imported medical devices and equipment used in vision correction procedures. This can result in higher treatment costs for patients, further deterring them from seeking timely interventions.

Opportunities:

• Emerging markets expansion
• Customized treatment options
• Telemedicine advancements
• Strategic partnerships formation

• Research on gene therapy - Research on gene therapy represents a transformative opportunity in the global myopia and presbyopia treatment market. Gene therapy aims to address underlying genetic factors contributing to refractive errors, offering potential long-term solutions that go beyond conventional corrective measures.

  Recent advancements in molecular genetics have identified specific genes associated with myopia progression and presbyopia development. Targeted gene therapies aim to modify or correct these genetic abnormalities, potentially slowing or halting the progression of refractive errors in affected individuals.

  Moreover, gene editing technologies such as CRISPR-Cas9 have revolutionized the precision and feasibility of genetic interventions, opening new avenues for therapeutic developments in ophthalmology. These technologies enable researchers to precisely edit and modify genetic sequences implicated in myopia and presbyopia, paving the way for personalized treatment approaches tailored to individual genetic profiles.

Key players in Global Myopia & Presbyopia Treatment Market include:

• AbbVie Inc.
• Alcon Inc.
• Arctic Vision
• Bausch Health Companies Inc.
• BVI Holdings Ltd.
• Carl Zeiss AG
• ENTOD INTERNATIONAL
• EssilorLuxottica
• F. Hoffmann La Roche Ltd.
• Johnson and Johnson
• Metall Zug AG
• NIDEK Co. Ltd.
• Ophtec BV

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis